scispace - formally typeset
Search or ask a question

Showing papers by "Gabriel Lopez-Berestein published in 2007"


Patent
05 Oct 2007
TL;DR: In this paper, a method for treating cancer comprising of inhibiting transglutaminase activity is provided. But the method is not suitable for all cancer types for which the methods of the present disclosure can be used to treat.
Abstract: A method for treating cancer comprising inhibiting transglutaminase activity is provided. Suitable cancer types for which the methods of the present disclosure can be used to treat include, but are not limited to, pancreatic, breast, and ovarian cancers and melanoma. The inhibition of transglutaminase activity may be performed by one or more techniques, including, but not limited to, downregulating transglutaminase expression, inhibiting TG2 translation, or blocking TG2 enzymatic activity, such as with a small molecule inhibitor or intracellular antibody (intrabody).

10 citations


Patent
29 Oct 2007
TL;DR: The wrapping technology described in this article is a novel form of rational drug design for avoiding side effects in drug therapy and sharpening the inhibitory impact of drugs on the oncokinome.
Abstract: This application describes a novel technology in drug discovery and drug-based imaging/detection: the wrapping technology This technology is based on identified singularities in the structure of soluble proteins In contrast with drug-design approaches based on standard structural considerations, the packing of a protein, or more precisely, its dehydron pattern, may be used as a selectivity filter to design small-molecule inhibitors The wrapping technology described herein is a novel form of rational drug design for avoiding side effects in drug therapy and sharpening the inhibitory impact of drugs on the oncokinome

8 citations